Difficulty: Medium
Average Score: 87%
Practice
Which of the following drugs improves some symptoms in Alzheimer's dementia by increasing brain acetylcholine levels?
Correct answer
B
Rationale
The correct answer is B) Tacrine. Tacrine is a centrally acting cholinesterase inhibitor that helps improve some symptoms in Alzheimer's dementia by increasing brain acetylcholine levels. Acetylcholine is a neurotransmitter that plays a crucial role in memory and learning. By inhibiting the breakdown of acetylcholine, tacrine enhances cholinergic transmission, which can help alleviate cognitive decline in Alzheimer's patients.
Now, let's discuss why the other options are incorrect:
A) Pemoline: Pemoline is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It does not have a direct impact on acetylcholine levels in the brain and is not indicated for Alzheimer's dementia.
C) Nicergoline: Nicergoline is a drug used to improve symptoms of cognitive impairment and dementia, but it works through different mechanisms such as enhancing cerebral blood flow and oxygen utilization. It does not directly increase brain acetylcholine levels like cholinesterase inhibitors.
D) Piribedil: Piribedil is a dopamine agonist primarily used in the treatment of Parkinson's disease. It does not target acetylcholine levels in the brain and is not indicated for Alzheimer's dementia treatment.
In an educational context, understanding the mechanisms of action of CNS drugs is crucial for healthcare professionals involved in the care of patients with neurological disorders. Knowing how each drug works allows for appropriate selection based on the underlying pathology. In the case of Alzheimer's dementia, cholinesterase inhibitors like tacrine are valuable in managing cognitive symptoms by addressing the neurotransmitter imbalance in the brain.
Now, let's discuss why the other options are incorrect:
A) Pemoline: Pemoline is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It does not have a direct impact on acetylcholine levels in the brain and is not indicated for Alzheimer's dementia.
C) Nicergoline: Nicergoline is a drug used to improve symptoms of cognitive impairment and dementia, but it works through different mechanisms such as enhancing cerebral blood flow and oxygen utilization. It does not directly increase brain acetylcholine levels like cholinesterase inhibitors.
D) Piribedil: Piribedil is a dopamine agonist primarily used in the treatment of Parkinson's disease. It does not target acetylcholine levels in the brain and is not indicated for Alzheimer's dementia treatment.
In an educational context, understanding the mechanisms of action of CNS drugs is crucial for healthcare professionals involved in the care of patients with neurological disorders. Knowing how each drug works allows for appropriate selection based on the underlying pathology. In the case of Alzheimer's dementia, cholinesterase inhibitors like tacrine are valuable in managing cognitive symptoms by addressing the neurotransmitter imbalance in the brain.